Groundbreaking Discovery: Complete Cancer Cure Expected Within a Year
The Method to Get Rid of Lice Quickly and Cheaply:
A small research team of Israeli scientists claims they have the first “complete cure” for cancer ready within a year, Forbes reports.
In an article published in the Jerusalem Post, Forbes mentions some groundbreaking claims by the scientists that could potentially revolutionize the medical world.
Not only is it claimed that the cancer cure will be ready within a year, but it would also be a cheap, short-term treatment with no side effects…
Dan Aridor, CEO of Accelerated Evolution Biotechnologies Ltd. says: “We believe we will have a complete cancer cure within a year.”
Founded in 2000 and located in Rehovot, Israel, this organization is working on the discovery and development of therapeutic solutions against cancer.
The claim
“Our cancer cure will be effective from the first day and will only last a few weeks. It will also have few or no side effects and cost much less than most treatments on the market,” says Aridor.
“Our solution will be for everyone but also tailored.”
The drug, MuTaTo (multi-target toxin), is described as an antibiotic for cancer. The Jerusalem Post writes that MuTaTo was based on the AEBI technology. The article states:
“Scientists developed a DNA code for a protein, like an antibody that infects cancer bacteria. The protein then appears on the surface of the bacteria.”
According to the Jerusalem Post, the organization has also done similar work with the same team of scientists who have won the Nobel Prize for their work in developing new proteins.
How it works
Dr. Ilan Morad, CEO of the organization, told the Jerusalem Post: “Targeting cancer usually affects a physiological route that actually promotes cancer. Mutations in the targets could render the targets irrelevant to the cancer cell. Therefore, the drug attacking it would not be effective.”
“But MuTaTo, on the other hand, is a combination of several cancer-fighting agents for each cancer cell individually. This, in combination with a strong toxin that can specifically kill the cancer cells,” Morad explained.
3 against 1
“By using at least 3 peptides with a strong toxin, we have ensured that the treatment will not be affected by mutations. Because cancer cells can mutate, blocking the drug from affecting the cancer.”
“The likelihood of having multiple mutations that would all simultaneously change targeted receptors dramatically decreases with the number of targets used. Instead of attacking receptors one by one, we attack receptors three at a time. And even cancer cannot mutate three receptors simultaneously.”
The MuTaTo drug with the triple drug cocktail has also significantly lowered the death rate of AIDS patients. But Morad says the cancer treatment will ultimately be designed specifically for each patient.
Just a few weeks of treatment
Furthermore, patients may likely be able to stop using MuTaTo after just a few weeks, instead of lifelong use of the drug.
Incredibly exciting news, we can probably all agree on that!
